| Literature DB >> 28743872 |
Maria Carliana Mota1, Catarina Mendes Silva1, Laura Cristina Tibiletti Balieiro1, Walid Makin Fahmy2, Cibele Aparecida Crispim3.
Abstract
Social jetlag - a measure of disruption of the circadian system - has been linked to obesity, but its association with metabolic complications in non-communicable chronic diseases (NCCDs) is unknown in the literature. We examined the associations between social jetlag and obesity status and metabolic parameters among individuals with NCCDs. Patients (n = 792) with NCCDs (obesity, systemic arterial hypertension, type 2 diabetes mellitus or dyslipidaemia) attended clinics of the public health service of the city of Uberlândia, Minas Gerais State, Brazil. They were classified in three obesity statuses: non-obese: BMI < 30 kg/m2; metabolically healthy obese (MHO): BMI ≥ 30 kg/m2 and less than three high-risk biomarkers for metabolic syndrome; and metabolically unhealthy obese (MUO): BMI ≥ 30 kg/m2 and with high-risk values on three or more biomarkers for metabolic syndrome. After adjustments for confounding variables, social jetlag was positively associated with fasting glucose levels among all subjects (β = 0.08, p = 0.03) and MUO subjects (β = 0.32, p < 0.001). Patients with social jetlag (>1 h) presented a significant odds ratio (OR) of being overweight (OR = 2.0, confidence interval (CI) = 1.2-3.6, p = 0.006) and MUO (OR = 1.8, CI = 1.1-2.8, p = 0.01). These results suggest that social jetlag is associated with a higher risk of overweight and related metabolic complications in individuals with NCCDs.Entities:
Mesh:
Year: 2017 PMID: 28743872 PMCID: PMC5526860 DOI: 10.1038/s41598-017-06723-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics, employment status, anthropometric, health behaviors, physical activity, sleep, social jetlag and metabolic variables according to obesity status (n = 792)
| Variables | All (n = 792) | Non-obese (n = 369) | MHO (n = 252) | MUO (n = 171) | p* |
|---|---|---|---|---|---|
| Age (years) | 55.9 ± 12.4 | 55.6 ± 12.3 | 55.4 ± 13.4 | 56.4 ± 13.6 | 0.17 |
| Female (%) | 581 (73.0) | 269 (73.1) | 189 (75.3) | 122 (71.3) | 0.65 |
| Marital status – Married (%) | 401 (51.0) | 188 (51.0) | 131 (52.0) | 82 (48.5) | 0.42 |
| Family income – (U$ 553.0) | 504 (63.0) | 235 (63.7) | 151 (60.0) | 118 (69.4) | 0.36 |
| Education – <= 12 years | 507 (64.0) | 231 (62.6) | 165 (65.4) | 123 (72.0) | 0.37 |
| Employment status | |||||
| Day workers (%) | 333 (42.0) | 144 (38.7) | 96 (40.0) | 68 (39.6) | 0.88 |
| Retired (%) | 256 (32.0) | 132 (36.3) | 91 (33.6) | 57 (33.5) | |
| Hours per week | 40.8 ± 8.9 | 41.0 ± 6.7 | 39.4 ± 7.9 | 42.4 ± 7.1 | 0.12 |
| Ex-night worker | 37 (5.0) | 22 (2.8) | 7 (4.7) | 8 (6.0) | 0.17 |
| Health behaviours | |||||
| Smoking status – Yes (%) | 96 (12.0) | 55 (15.0) | 27 (10.7) | 14 (8.1) | 0.05 |
| Alcohol intake – Yes (%) | 220 (28.0) | 103 (28.0) | 75 (29.7) | 41 (24.0) | 0.26 |
| Alcohol – Servings/week | 2.0 [0.75–6.0] | 2.0 [0.5–7.0] | 2.0 [1.0–5.2] | 2.3 [0.5–5.0] | 0.86 |
| Physical activity (PA) – Yes (%) | 294 (37.0) | 134 (36.4) | 93 (37.0) | 67 (39.1) | 0.82 |
| Minutes of PA/week | 180 [120–300] | 190 [120–300] | 170 [120–300] | 180 [120–290] | 0.31 |
| Chronic diseases | |||||
| Type 2 diabetes mellitus (TD2) (%) | 257 (33.0) | 111 (30.0) | 57 (22.6) | 89 (52.3) |
|
| Arterial hypertension (SAH) (%) | 526 (66.4) | 223 (63.0) | 174 (69.0) | 129 (75.4) |
|
| Dyslipidemia (%)⚲ | 324 (41.0) | 148 (40.0) | 89 (35.4) | 87 (50.8) |
|
| Time of diagnosis of TD2λ | 5.0 [3.0–10.0] | 6.0 [3.0–10.0] | 9.5 [4.0–16.0] | 6.0 [3.0–10.0] | 0.63 |
| Time of diagnosis of SAHλ | 10 [5.0–15.0] | 10.0 [5.0–15.0] | 8.0 [2.0–15.0] | 10.0 [5.0–18.0] | 0.15 |
| Time of diagnosis of dyslipidaemiaλ | 5.0 [2.0–10.0] | 4.0 [2.0–8.0] | 4.0 [2.0–10.0] | 5.0 [3.0–10.0] | 0.13 |
| Anthropometric | |||||
| BMI (kg/m2) | 30.0 ± 6.3 | 25.1 ± 0.2a | 33.4 ± 0.2b | 33.6 ± 0.3b |
|
| Abdominal obesity (%)Ω | 564 (71.0) | 173 (47.0) | 224 (89.0) | 167 (98.0) |
|
| High neck circumference (%)Φ | 518 (65.0) | 155 (42.2) | 209 (83.2) | 154 (90.0) |
|
| Food intake | |||||
| Kcal (kcal/day) | 1467.5 [1212.3–1796.8] | 1439.5 [1199.5–1764.8] | 1496.4 [1221.5–1857.3] | 1511.1[1254.0–1860.0] | 0.34 |
| Carbohydrate (g/day) | 174.1 [137.0–215.1] | 170.0 [136.1–213.6] | 181.2 [136.3–226.5] | 174.1 [137.0–215.1] | 0.21 |
| Protein intake (g/day) | 73.9 [55.7–98.8] | 73.1 [56.4–94.6] | 77.0 [55.0–104.2] | 75.4 [56.3–102.7] | 0.58 |
| Fat intake (g/day) | 51.0 [35.2–69.0] | 51.0 [34.5–67.3] | 52.4 [36.4–73.2] | 51.0 [35.2–70.0] | 0.74 |
| Kcal after 9 p.m. (kcal/day) | 0 [0–165.4] | 0 [0–204.8] | 0 [0–138] | 0 [0–130.0] | 0.70 |
| Circadian | |||||
| Chronotype – MSFsc (h)Ψ | 02:54 [02:06–03:48] | 02:48 [02:00–02:42] | 02:59 [2:07–03:49] | 02:55 [02:12–03:54] | 0.72 |
| Morning (%) | 633 (79.0) | 296 (80.2) | 197 (78.1) | 139 (81.2) | 0.83 |
| Intermediate (%) | 77 (9.7) | 33 (9.0) | 29 (11.5) | 15 (8.8) | |
| Late (%) | 83 (10.4) | 40 (10.8) | 26 (10.3) | 17 (10.0) | |
| Bedtime weekday (h)δ | 22:20 [21:20–23:20] | 22:20 [21:49–23:00] | 22:22 [21:20–23:30] | 22:24 [21:13–23:25] | 0.93 |
| Bedtime weekend (h)δ | 22:50 [21:50–24:00] | 22:48 [21:37–23:00] | 22:55 [21:52–23:55] | 22:49 [21:50–23:51] | 0.35 |
| Waketime weekday (h)δ | 06:00 [05:30–07:00] | 06:00 [05:30–07:00] | 06:22 [06:00–07:00] | 06:00 [05:30–07:30] | 0.43 |
| Waketime weekend (h δ | 07:00 [06:00–08:30] | 07:00 [06:00–08:30] | 07:00 [06:00–08:30] | 07:00 [06:00–08:00] | 0.48 |
| Sleep duration weekday (h) | 07:30 [06:30–09:00] | 07:30 [07:00–09:00] | 07:30 [06:30–09:00] | 07:00 [06:30–09:00] | 0.32 |
| Sleep duration weekend (h) | 08:00 [07:00–09:00] | 08:00 [07:00–09:00] | 08:00 [07:00–09:00] | 08:00 [07:30–09:00] | 0.36 |
| Mean sleeping duration (h) | 07:29 ± 01:50 | 07:36 ± 01:47 | 07:25 ± 02:05 | 07:23 + 01:50 | 0.65 |
| Social jetlag (h) | 00:30 [00:00–01:00] | 00:30 [00:00–01:00] | 0:30 [0:00–01:00] | 0:25 [0:00–01:15] | 0.97 |
| Social jetlag <= 1 h (%) | 524 (66.0) | 279 (75.6) | 193 (76.6) | 126 (73.6) | 0.42 |
| Social jetlag >1 h and <2 h (%) | 117 (14.0) | 48 (13.0) | 39 (15.4) | 30 (17.4) | |
| Social jetlag > = 2 h (%) | 77 (10.0) | 42 (11.3) | 20 (8.0) | 15 (9.0) | |
*One-way ANOVA and Tukey post hoc analyses were performed for normally distributed variables. When the variables were not normally distributed, Kruskal–Wallis tests were used. Variables with significant values in the Kruskal–Wallis test were tested by Dunn’s test with a correction of alpha via Bonferroni’s method. Values are presented as mean and SD for normally distributed data or as median (interquartile range) for non-normally distributed data. ΨChronotype (MSF) was derived from time of mid-sleep on free days (weekend), with further correction for calculated sleep debt – the difference between average sleep duration at weekends and on weekdays. δTime is presented in 24-h clock time. ⚲Diagnosis of hypercholesterolaemia, hypertriglyceridaemia or reduced HDL-C. ΩWaist circumference ≥ 102 cm for men and ≥ 88 cm for women were considered abdominal obesity. ΦNeck circumference ≥ 39 cm for men and ≥ 35 cm for women were considered high. λOnly those reported to have type 2 diabetes mellitus, systemic arterial hypertension or dyslipidaemia were included. ΧOnly those reported to perform physical activities. BMI: Body mass index. MHO: Metabolically healthy obese. MUO: Metabolically unhealthy obese.
Associations between social jetlag and anthropometric, metab olic parameters and blood pressure according to obesity status (n = 792)
| All (n = 792) | Non-obese (n = 369) | MHO (n = 252) | MUO (n = 171) | |||||
|---|---|---|---|---|---|---|---|---|
| β | p | β | p | β | p | β | p | |
| BMI (Kg/m2) | 0.03 | 0.38 | 0.02 | 0.65 | −0.06 | 0.38 | −0.03 | 0.53 |
| Waist circumference, cm | 0.01 | 0.84 | 0.02 | 0.69 | 0.01 | 0.98 | 0.08 | 0.21 |
| Neck circumference, cm | −0.01 | 0.88 | −0.01 | 0.76 | −0.03 | 0.68 | 0.03 | 0.62 |
| Weight gain, kg | −0.04 | 0.37 | 0.04 | 0.76 | −0.08 | 0.44 | −0.01 | 0.90 |
| Fasting glucose, mg/dL | 0.08 |
| 0.08 | 0.14 | −0.05 | 0.63 | 0.32- |
|
| Glycated haemoglobin, % | 0.01 | 0.82 | −0.02 | 0.68 | 0.10 | 0.53 | 0.01 | 0.82 |
| Total cholesterol, mg/dL | 0.02 | 0.59 | 0.02 | 0.72 | 0.01 | 0.89 | 0.19 |
|
| HDL-c, mg/dL | 0.05 | 0.15 | 0.09 | 0.12 | 0.05 | 0.60 | 0.13 | 0.16 |
| LDL-c, mg/dL | −0.01 | 0.80 | −0.04 | 0.48 | 0.01 | 0.87 | 0.08 | 0.39 |
| Triglycerides, mg/dL | 0.04 | 0.26 | 0.07 | 0.27 | −0.08 | 0.30 | 0.33 |
|
| Systolic BP, mm Hg | 0.01 | 0.65 | −0.04 | 0.49 | 0.13 | 0.23 | 0.03 | 0.72 |
| Diastolic BP, mm Hg | 0.01 | 0.91 | 0.01 | 0.81 | −0.08 | 0.44 | 0.07 | 0.42 |
ΦMultivariate linear regressions analysis adjusted for age, sex, family income, time of diagnosis of type 2 diabetes mellitus, insulin use, minutes of physical activity per week, mean of sleep time. δMultivariate linear regressions analysis adjusted for age, sex, family income, time of diagnosis of type 2 diabetes mellitus, time of diagnosis of dyslipidaemia, insulin use, use of antidepressants and mean of sleep time. Multivariate linear regressions analysis adjusted for age, sex, family income, employment status, time of diagnosis of dyslipidaemia and use of sleeping pills. Χr2 adjusted = 0.11; Ωr2 adjusted = 0.13; ψr2 adjusted = 0.01; r2adjusted = 0.23. MHO: Metabolically healthy obese. MUO: Metabolically unhealthy obese.
Odds ratio (OR) for comparison of effects of social jetlag (>1 h) versus no social jetlag (≤1 h) on overweight, obese or metabolically unhealthy obesity (n = 792)
| Overweight⚲ | ObeseΧ | MUOδ | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |
| Crude | 1.8 (1.2–2.7) |
| 1.0 (0.8–1.5) | 0.60 | 1.2 (0.8–1.7) | 0.30 |
| Adjusted model | 2.0 (1.2–3.6)ψ |
| 1.1 (0.7–1.6) | 0.53 | 1.8 (1.1–2.8)Φ |
|
ψMultivariate logistic regressions analysis adjusted model for age, sex, employment status, insulin use, use of sleeping pills, use of antidepressants and time of diagnosis of type 2 diabetes mellitus, systemic arterial hypertension or dyslipidaemia. ΦMultivariate logistic regressions analysis adjusted model for age, sex, insulin use, use of sleeping pills, minutes of physical activity per week, and time of diagnosis of type 2 diabetes mellitus, systemic arterial hypertension or dyslipidaemia. ⚲Overweight (BMI ≥ 25 kg/m2). ΧObese (BMI ≥ 30 kg/m2). δMUO (BMI ≥ 30 kg/m2 and high-risk values on three or more biomarkers for metabolic syndrome). CI: confidence intervals. MUO: Metabolically unhealthy obese. OR: odds ratio.